Stories have been going around that the anti-viral pill, Molnupiravir, will make its way to the Philippines this November. Here’s what we know so far.
Last October 27, 2021, it was announced that Molnupiravir is coming to the Philippines this November. For those who are wondering, Molnupiravir is supposedly an experimental anti-viral drug to make COVID-19 take a hike. Will having Molnupiravir mean our kids can go back to attending face-to-face classes? Will our teens be able to have fun with their friends again? When is Molnupiravir coming? Don’t worry—we’ll be updating this story to keep everyone informed about it.
What We Know About Molnupiravir
Molnupiravir is an experimental anti-viral drug that’s meant to fight COVID-19. With this, it’ll not only clear up hospitals but also keep the hospital bills to a minimum. We’ve heard horror stories on how COVID-19 hospital bills can spike past millions without the certainty of survival. But with Molnupiravir, it’s possible to stop COVID-19 from killing our loved ones and wallets. It prevents COVID-19 from multiplying and attacking the rest of the body before the effects get severe.
How are the results so far?
Molnupiravir is shown to drop a person’s chances of dying from COVID-19 to 50%. The tests have been running since October 2, 2021, and so far, the drug has been showing good progress. Those who received Molnupiravir to fight COVID-19 fared better than those who only received the placebo. Although the tests are not being done in the Philippines, the Department of Health has been keeping tabs on the clinical trials of Molnupiravir in the US.
When will it be available for us?
We don’t know yet but they’re currently trying to price Molnupiravir into something more affordable for all Filipinos, especially those who are frontliners — both medical and non-medical. There are stories circulating between PHP 100.00 ~ PHP 130.00 but we’re not sure yet as to when it’ll be available in our local drugstores. We’ll keep updating this story so that we can help contribute to the fight against COVID-19.
How safe is it?
Unfortunately, the age specifics for Molnupiravir are not clear yet. But out of their 775 participants, they considered being senior citizens as a risk factor. That, along with obesity, can affect the efficacy of the drug. For kids, we might have to bring them to their pediatricians to give them a scratch test or check for allergies if they don’t respond to anti-virals well. Most of all, make sure that kids get vaccinated as soon as possible! The fewer chances they have of getting it, the fewer white hairs we’re going to grow out of worry. But for now, we have to stick to the lockdown rules.